The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs
Autors principals: Taieb, Julien, Jung, Andreas, Sartore-Bianchi, Andrea, Peeters, Marc, Seligmann, Jenny, Zaanan, Aziz, Burdon, Peter, Montagut, Clara, Laurent-Puig, Pierre
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728290/
https://ncbi.nlm.nih.gov/pubmed/31347092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01165-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars